Intestinal mast cell polymorphism: new research directions and clinical implications.
D000420:Albuterol / Q000494:pharmacology; D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000276:immunology; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D004205:Cromolyn Sodium / Q000494:pharmacology; D005512:Food Hypersensitivity / Q000188:drug therapy; D006801:Humans; D006965:Hyperplasia; D006969:Hypersensitivity, Immediate / Q000473:pathology; D007249:Inflammation / Q000473:pathology; D007413:Intestinal Mucosa / Q000166:cytology; D007422:Intestines / Q000166:cytology*; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism / Q000473:pathology / Q000502:physiology*; D051379:Mice; D009928:Organ Specificity; D010537:Peritoneum / Q000166:cytology; D011110:Polymorphism, Genetic; D051381:Rats; D012106:Research; D013045:Species Specificity; D013806:Theophylline / Q000494:pharmacology
D013806:Theophylline; D004205:Cromolyn Sodium; D000420:Albuterol